- Kurin, Inc. announces peer-reviewed publication on Kurin® efficacy from Central Texas Veterans Health Care System
- Kurin, Inc. honored by MD Tech Review in annual listing of top Infection Control solutions
- Kurin, Inc. Named to Inc.’s Inaugural Best in Business List in the Prosperous and Thriving Category
- Kurin, Inc. Receives Allowance from United States Patent and Trademark Office of Additional Claims to its Innovative Blood Culture Collection Device.
- Kurin, Inc. Reports Record Revenues
- Kurin, Inc. Receives Supplier Horizon Award from Premier Inc.
- Kurin, Inc. continues sales growth with record month.
- Kurin, Inc. Announces Agreement with Intalere for Kurin Lock to impact contaminated blood cultures
- Kurin, Inc. Announces Agreement with Vizient for Kurin Lock to help reduce contaminated blood cultures
- Kurin, Inc. receives FDA 510k clearance for its push-button needle
- Kurin, Inc. Announces Hire of EVP Operations Amid Record Growth
- Kurin, Inc. Reports Record Third Quarter Revenues
- Kurin, Inc. receives CE Mark for its novel Kurin Lock®
- Kurin Inc. Responds to Allegations Published by Magnolia Medical Regarding Patent Infringement
- Kurin, Inc. CEO Addresses Patent Infringement Lawsuit Brought by Magnolia Medical
- Kurin, Inc. receives FDA 510k clearance for its novel Kurin Lock with peripheral IV infusion set.
- Kurin, Inc. announces clinical results on Kurin® efficacy from Central Texas Veterans Health Care System
- Kurin, Inc. Announces Agreement with Premier for Kurin Lock® to help impact contaminated blood cultures
- Kurin, Inc. Announces Educational Website on the Importance of Improving Value of the Blood Culture Test
- Clinical results of Kurin specimen diversion technology signal a shift in the blood culture collection standard of care.
The problem with false-positive blood cultures
Determining whether a bloodstream infection exists is critical to the wellbeing of patients and the financial health of hospitals.
A blood culture test is the gold standard for identifying bacteremia.
Each year, millions of blood culture tests inform patient care decisions in the U.S. The majority will find no infection.1 But, of the cultures that test positive, almost 1/3 are false-positive results.
When blood cultures test positive—whether true or false—immediate action is taken to treat the patient with antibiotic therapy.
Roughly 20% of the microbes present in skin reside deep in the dermis layer and may be drawn into blood samples.2 Without a way to avoid these microbes, hospitals have accepted high rates of seemingly unavoidable false positives.